Ovom Care
Lynae Brayboy, MD has a diverse work experience in the field of reproductive care. Lynae currently holds the position of Chief Medical Officer at OVōM Care, a company that combines in-person care with AI-based technology to redefine reproductive care and improve accessibility for patients. Prior to this, they served as Chief Medical Officer at Clue by Biowink, where they worked from July 2020 to January 2023.
Dr. Brayboy has also worked as a Reproductive Scientist at Charité since August 2020 and as a Junior Faculty Research Scholar at the Global Consortium for Reproductive Longevity and Equity since August 2020. Lynae has previously held the role of Adjunct Professor at Brown University from June 2020 to January 2023 and served as an Assistant Professor at Women and Infants Hospital from July 2014 to July 2020. Lynae was also a College of Life Sciences Fellow at the Wissenschaftskolleg Berlin, Institute for Advanced Study from September 2019 to January 2020.
Additionally, they have a background in reproductive medicine and has completed a REI Fellowship at Women and Infants from June 2011 to June 2014. Lynae also participated in the Frontiers in Reproduction program at the Marine Biological Laboratory in April 2013 for a limited time.
Overall, Dr. Brayboy's work experience demonstrates their expertise in reproductive care and their commitment to advancing the field through research, teaching, and leadership positions.
Lynae Brayboy, MD completed their Bachelor's degree in Biology, General at Florida Agricultural and Mechanical University from 1998 to 2002. Lynae then pursued their medical education at Temple University - Lewis Katz School of Medicine, where they obtained their Doctor of Medicine (M.D.) degree between 2003 and 2007.
This person is not in any teams
This person is not in any offices
Ovom Care
Ovom redefines how reproductive care is brought to patients by combining modern in-person care with advanced AI-based technology. Catering not just to patients but also to healthcare professionals, we create an ecosystem that allows for increased success rates, improved accessibility, and reduced life disruption for patients.